Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Laurent Siproudhis
Editorial: Infliximab De-Escalation in Inflammatory Bowel Disease Using a Therapeutic Drug Monitoring Strategy - Early Promise but More Data Needed. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Anal Cancer: French Intergroup Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP)
Digestive and Liver Disease
Hepatology
Gastroenterology
Related publications
Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Gastroenterology
Hepatology
Gastroenterology
Editorial: Treating Strictures in Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Letter: Infliximab Therapy for Patients With Inflammatory Bowel Disease - Some Unanswered Questions. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Probiotics in Inflammatory Bowel Disease-Wrong Organisms, Wrong Disease, or Flawed Concepts? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Weighing the Global Risk of Cancer With Thiopurines in Inflammatory Bowel Disease-Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Vedolizumab Drug Levels in Cord and Maternal Blood in Women With Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: De Novo Inflammatory Bowel Disease Following Bariatric Surgery-Potential Implications for Research and Clinical Practice. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
